3-cyanothiophene derivatives as inhibitors of the pd-1/pd-l1 protein/protein interaction AB

Dömling, A., 10-Jan-2019, Patent No. WO2019008152, 6-Jul-2018, Priority date 7-Jul-2017

Research output: PatentProfessional

The present invention provides novel compounds of formula (I) that are useful as inhibitors of the PD-l/PD-Ll protein/protein interaction. The compounds may be used in the treatment of cancer, infectious diseases and neurodegenerative diseases such as schizophrenia, Alzheimer, multiple sclerosis or Parkinson.
Original languageEnglish
Patent numberWO2019008152
Priority date07/07/2017
Filing date06/07/2018
Publication statusPublished - 10-Jan-2019

ID: 81192045